Erstellt von fchar99
Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals Inc.
WKN: A2AGYB / Symbol: ARWR / Name: Arrowhead Pharma / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
56,30 €
0,71 %
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at HC Wainwright from $80.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Bank of America Corporation from $62.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Royal Bank Of Canada from $52.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Piper Sandler from $70.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Chardan Capital from $60.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00.
Ratings data for ARWR provided by MarketBeat
Neueste Beiträge
Sanford_C__Bernstein in KLA-Tencor Corp. diskutieren